Nuzenio

Immunovant

Immunovant news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 19:42:39 GMTOppenheimer Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $54 - Moomoo
Thu, 06 Aug 2026 21:51:11 GMTImmunovant, Inc. Q1 2027 Earnings Call Summary - Yahoo Finance
Thu, 06 Aug 2026 19:04:19 GMTImmunovant Q1 Earnings Call Highlights - Yahoo Finance
Thu, 06 Aug 2026 17:20:18 GMTImmunovant, Inc. Stock 12‑Month Price Target Raised to $47.56, Implies 21% Upside - TradingView
Thu, 06 Aug 2026 15:22:00 GMTImmunovant's Q1 Loss Wider Than Expected, Pipeline in Progress - Yahoo Finance
Thu, 06 Aug 2026 13:32:01 GMTImmunovant, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Immunovant.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.